293 related articles for article (PubMed ID: 26531756)
1. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
2. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
Domingo L; Salas D; Zubizarreta R; Baré M; Sarriugarte G; Barata T; Ibáñez J; Blanch J; Puig-Vives M; Fernández A; Castells X; Sala M;
Breast Cancer Res; 2014 Jan; 16(1):R3. PubMed ID: 24410848
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
4. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
6. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
[TBL] [Abstract][Full Text] [Related]
7. Mammographic features associated with interval breast cancers in screening programs.
Boyd NF; Huszti E; Melnichouk O; Martin LJ; Hislop G; Chiarelli A; Yaffe MJ; Minkin S
Breast Cancer Res; 2014 Aug; 16(4):417. PubMed ID: 25346388
[TBL] [Abstract][Full Text] [Related]
8. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
9. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
10. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
[TBL] [Abstract][Full Text] [Related]
11. Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer.
Sartor H; Zackrisson S; Elebro K; Hartman L; Borgquist S
Cancer Causes Control; 2015 Jun; 26(6):931-9. PubMed ID: 25860114
[TBL] [Abstract][Full Text] [Related]
12. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
[TBL] [Abstract][Full Text] [Related]
13. Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.
Holloway CMB; Jiang L; Whitehead M; Racz JM; Groome PA
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1769-1775. PubMed ID: 29909564
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
15. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study.
Pollán M; Ascunce N; Ederra M; Murillo A; Erdozáin N; Alés-Martínez J; Pastor-Barriuso R
Breast Cancer Res; 2013 Jan; 15(1):R9. PubMed ID: 23360535
[TBL] [Abstract][Full Text] [Related]
16. PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.
Puvanesarajah S; Nyante SJ; Kuzmiak CM; Chen M; Tse CK; Sun X; Allott EH; Kirk EL; Carey LA; Perou CM; Olshan AF; Henderson LM; Troester MA
Cancer Prev Res (Phila); 2018 Jun; 11(6):327-336. PubMed ID: 29622545
[TBL] [Abstract][Full Text] [Related]
17. Radiologic findings of screen-detected cancers in an organized population-based screening mammography program in Turkey.
Kayhan A; Arıbal E; Şahin C; Taşçı ÖC; Özkan Gürdal S; Öztürk E; Hatipoğlu HH; Özaydın N; Cabioğlu N; Özçınar B; Özmen V
Diagn Interv Radiol; 2016; 22(6):508-513. PubMed ID: 27705880
[TBL] [Abstract][Full Text] [Related]
18. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review.
Hoff SR; Abrahamsen AL; Samset JH; Vigeland E; Klepp O; Hofvind S
Radiology; 2012 Aug; 264(2):378-86. PubMed ID: 22700555
[TBL] [Abstract][Full Text] [Related]
20. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
